|
Minerva Neurosciences, Inc. (NERV) Valoración de DCF
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Minerva Neurosciences, Inc. (NERV) Bundle
¡Explore las perspectivas financieras de Minerva Neurosciences, Inc. (NERV) con nuestra calculadora DCF fácil de usar! Ingrese sus proyecciones para el crecimiento, los márgenes y los gastos para calcular el valor intrínseco de Minerva Neurosciences, Inc. (NERV) y refinar su enfoque de inversión.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | 41.2 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | -100 | 0 | 0 | -25 | -25 | -25 | -25 | -25 |
| EBITDA | -74.3 | 1.9 | -51.6 | -24.7 | -21.7 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | 4.68 | 100 | 100 | 100 | 80.94 | 80.94 | 80.94 | 80.94 | 80.94 |
| Depreciation | .2 | .2 | .1 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 0.42787 | 100 | 100 | 100 | 80.09 | 80.09 | 80.09 | 80.09 | 80.09 |
| EBIT | -74.4 | 1.8 | -51.7 | -24.7 | -21.7 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | 4.26 | 100 | 100 | 100 | 80.85 | 80.85 | 80.85 | 80.85 | 80.85 |
| Total Cash | 45.9 | 25.4 | 60.8 | 36.1 | 41.0 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | 3.1 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 0 | 100 | 100 | 100 | 80 | 80 | 80 | 80 | 80 |
| Inventories | .0 | .0 | .0 | -3.0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 0 | 100 | 100 | 100 | 80 | 80 | 80 | 80 | 80 |
| Accounts Payable | 2.3 | 1.0 | 1.9 | 1.0 | 1.8 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 2.42 | 100 | 100 | 100 | 80.48 | 80.48 | 80.48 | 80.48 | 80.48 |
| Capital Expenditure | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | 0 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -72.2 | 1.8 | -49.9 | -30.0 | -21.7 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -69.7 | .6 | -48.9 | -31.0 | -20.8 | -1.8 | .0 | .0 | .0 | .0 |
| WACC, % | 9.12 | 9.38 | 9.09 | 9.38 | 9.38 | 9.27 | 9.27 | 9.27 | 9.27 | 9.27 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -1.7 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -2 | |||||||||
| Net Debt | -41 | |||||||||
| Equity Value | 39 | |||||||||
| Diluted Shares Outstanding, MM | 7 | |||||||||
| Equity Value Per Share | 6.03 |
What You Will Get
- Real Minerva Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for Minerva Neurosciences, Inc. (NERV).
- Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates specific to Minerva.
- Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Minerva’s fair value.
- Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections for Minerva Neurosciences, Inc. (NERV).
- Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility for Minerva.
Key Features
- Customizable Forecast Inputs: Adjust essential variables such as revenue growth, EBITDA %, and capital expenditures for accurate modeling.
- Instant DCF Valuation: Automatically computes intrinsic value, NPV, and other financial metrics in real time.
- High Precision Analytics: Leverages Minerva Neurosciences' (NERV) actual financial data for dependable valuation results.
- Simplified Scenario Analysis: Effortlessly evaluate various assumptions and analyze different outcomes.
- Efficiency Booster: Streamlines the valuation process, removing the need for intricate model construction from the ground up.
How It Works
- Download the Template: Gain immediate access to the Excel-based NERV DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and additional parameters.
- Instant Calculations: The model automatically recalculates Minerva Neurosciences' intrinsic value.
- Test Scenarios: Explore different assumptions to assess potential valuation shifts.
- Analyze and Decide: Utilize the results to inform your investment or financial evaluation.
Why Choose This Calculator for Minerva Neurosciences, Inc. (NERV)?
- Designed for Experts: A sophisticated tool utilized by healthcare analysts, investors, and financial advisors.
- Comprehensive Data: Minerva’s historical and anticipated financials preloaded for precision.
- Forecast Scenarios: Effortlessly simulate various projections and assumptions.
- Detailed Outputs: Automatically computes intrinsic value, NPV, and essential financial metrics.
- User-Friendly: Step-by-step guidance simplifies the entire calculation process.
Who Should Use This Product?
- Individual Investors: Make informed decisions about buying or selling Minerva Neurosciences, Inc. (NERV) stock.
- Financial Analysts: Streamline valuation processes with ready-to-use financial models specific to Minerva Neurosciences, Inc. (NERV).
- Consultants: Deliver professional valuation insights on Minerva Neurosciences, Inc. (NERV) to clients quickly and accurately.
- Business Owners: Understand how biotech companies like Minerva Neurosciences, Inc. (NERV) are valued to guide your own strategy.
- Finance Students: Learn valuation techniques using real-world data and scenarios related to Minerva Neurosciences, Inc. (NERV).
What the Template Contains
- Pre-Filled Data: Includes Minerva Neurosciences' historical financials and forecasts.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
- Key Financial Ratios: Analyze Minerva Neurosciences' profitability, efficiency, and leverage.
- Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
- Clear Dashboard: Charts and tables summarizing key valuation results.